CG Oncology
CGON
CGON
233 hedge funds and large institutions have $5.93B invested in CG Oncology in 2026 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 81 increasing their positions, 61 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
20% more funds holding
Funds holding: 194 → 233 (+39)
1.94% more ownership
Funds ownership: 102.44% → 104.38% (+1.9%)
8% less funds holding in top 10
Funds holding in top 10: 13 → 12 (-1)
Holders
233
Holding in Top 10
12
Calls
$213M
Puts
$87.2M
Top Buyers
| 1 | +$357M | |
| 2 | +$282M | |
| 3 | +$56.6M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$37.7M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
+$26.3M |
Top Sellers
| 1 | -$81.6M | |
| 2 | -$53.9M | |
| 3 | -$50.2M | |
| 4 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
-$39.3M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$35.6M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GCP
251
GSA Capital Partners
London,
United Kingdom
| – |
|
|||
|
BG
252
Bellevue Group
Kuesnacht,
Switzerland
| – |
|
|||
|
AB
253
Amalgamated Bank
New York
| – |
|
|||
254
Daiwa Securities Group
Tokyo,
Japan
| – |
|
|||
|
CCA
255
Cygnus Capital Advisors
Atlanta,
Georgia
| – |
|